Literature DB >> 7951242

Genomic organization of the human muscle chloride channel CIC-1 and analysis of novel mutations leading to Becker-type myotonia.

C Lorenz1, C Meyer-Kleine, K Steinmeyer, M C Koch, T J Jentsch.   

Abstract

The muscle chloride channel CIC-1 regulates the electric excitability of the skeletal muscle membrane. Mutations in the gene encoding this chloride channel (CLCN1) are responsible for both human purely myotonic disorders, autosomal recessive generalized myotonia (Becker's disease, GM) and autosomal dominant myotonia congenita (Thomsen's disease, MC). We now show that the protein-coding sequence of the CLCN1 gene is organized into 23 exons. The CIC-1 upstream region contains a canonical TATA box, several consensus binding sites for myogenic transcription factors and two other putative regulatory elements. SSCA analysis of a German GM family revealed that affected members are compound heterozygotes having two novel mutations. G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14 leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S). Functional expression of R496S cRNA in Xenopus oocytes did not yield detectable currents. It neither suppressed wild-type currents in a co-expression assay, confirming it as a recessive mutation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951242     DOI: 10.1093/hmg/3.6.941

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

1.  Alternative splicing of ClC-6 (a member of the CIC chloride-channel family) transcripts generates three truncated isoforms one of which, ClC-6c, is kidney-specific.

Authors:  J Eggermont; G Buyse; T Voets; J Tytgat; H De Smedt; G Droogmans; B Nilius
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Alternative mRNA splice variants of the rat ClC-2 chloride channel gene are expressed in lung: genomic sequence and organization of ClC-2.

Authors:  S Chu; P L Zeitlin
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

Review 3.  ClC transporters: discoveries and challenges in defining the mechanisms underlying function and regulation of ClC-5.

Authors:  Leigh Wellhauser; Christina D'Antonio; Christine E Bear
Journal:  Pflugers Arch       Date:  2010-01-05       Impact factor: 3.657

Review 4.  Properties of voltage-gated chloride channels of the ClC gene family.

Authors:  T J Jentsch; W Günther; M Pusch; B Schwappach
Journal:  J Physiol       Date:  1995-01       Impact factor: 5.182

Review 5.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

6.  Modification of C1- transport in skeletal muscle of Rana temporaria with the arginine-binding reagent phenylglyoxal.

Authors:  J M Skydsgaard
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

7.  Novel muscle chloride channel mutations and their effects on heterozygous carriers.

Authors:  V Mailänder; R Heine; F Deymeer; F Lehmann-Horn
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

8.  Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia.

Authors:  C Meyer-Kleine; K Steinmeyer; K Ricker; T J Jentsch; M C Koch
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

9.  Myotonia congenita: novel mutations in CLCN1 gene.

Authors:  Xiao-Li Liu; Xiao-Jun Huang; Jun-Yi Shen; Hai-Yan Zhou; Xing-Hua Luan; Tian Wang; Sheng-Di Chen; Ying Wang; Hui-Dong Tang; Li Cao
Journal:  Channels (Austin)       Date:  2015-08-11       Impact factor: 2.581

10.  Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita.

Authors:  In-Soo Moon; Hyang-Sook Kim; Jin-Hong Shin; Yeong-Eun Park; Kyu-Hyun Park; Yong-Bum Shin; Jong Seok Bae; Young-Chul Choi; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.